| Attributes | Values |
|---|
| rdf:type
| |
| description
| - videnskabelig artikel (da)
- article científic (ca)
- articol științific (ro)
- articolo scientifico (it)
- artigo científico (gl)
- artigo científico (pt)
- artigo científico (pt-br)
- artikull shkencor (sq)
- artículo científico (es)
- bilimsel makale (tr)
- scienca artikolo (eo)
- vedecký článok (sk)
- vetenskaplig artikel (sv)
- vitenskapelig artikkel (nb)
- vitskapeleg artikkel (nn)
- vědecký článek (cs)
- wetenschappelijk artikel (nl)
- wissenschaftlicher Artikel (de)
- научная статья (ru)
- научни чланак (sr)
- מאמר מדעי (he)
- artikel ilmiah (id)
- article scientifique (fr)
- বৈজ্ঞানিক নিবন্ধ (bn)
- artículu científicu espublizáu en 2012 (ast)
- наукова стаття, опублікована в лютому 2012 (uk)
- scientific article published on 08 February 2012 (en)
- scientific article published on 08 February 2012 (en-ca)
- scientific article published on 08 February 2012 (en-gb)
- مقالة علمية نشرت في 08 فبراير 2012 (ar)
|
| publication date
| |
| publication date
| |
| language of work or name
| |
| language of work or name
| |
| author name string
| |
| author name string
| |
| rdfs:label
| - Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications (en)
- Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications (nl)
- Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications (ast)
|
| skos:prefLabel
| - Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications (en)
- Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications (nl)
- Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications (ast)
|
| name
| - Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications (en)
- Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications (nl)
- Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications (ast)
|
| title
| |
| title
| - Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| - 10.1053/J.GASTRO.2012.02.003
|
| is about
of | |
| is cites work
of | - Metabolic fate of fructose in human adipocytes: a targeted (13)C tracer fate association study
- The Gordian Knot of dysbiosis, obesity and NAFLD.
- Cannabinoid receptor 1 promotes hepatic lipid accumulation and lipotoxicity through the induction of SREBP-1c expression in zebrafish.
- A high-risk phenotype associates with reduced improvement in glycaemia during a lifestyle intervention in prediabetes.
- High-fat diet triggers Mallory-Denk body formation through misfolding and crosslinking of excess keratin 8.
- Intestinal permeability--a new target for disease prevention and therapy
- Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas
- Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
- Non-alcoholic fatty liver disease: need for a balanced nutritional source
- Oleuropein prevents the progression of steatohepatitis to hepatic fibrosis induced by a high-fat diet in mice
- Identification of compounds from high-fat and extra virgin olive oil-supplemented diets in whole mouse liver extracts and isolated mitochondria using mass spectrometry
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- Impact of new-generation lipid emulsions on cellular mechanisms of parenteral nutrition-associated liver disease
- Nonalcoholic fatty liver disease
- Defining hepatic dysfunction parameters in two models of fatty liver disease in zebrafish larvae
- Hepatic inflammation and fibrosis: functional links and key pathways
- Cell death and cell death responses in liver disease: mechanisms and clinical relevance
- Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes
- Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?
- Can NASH be diagnosed, graded, and staged noninvasively?
- Meta-omic platforms to assist in the understanding of NAFLD gut microbiota alterations: tools and applications
- Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet
- NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications.
- Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD).
- The future of thiazolidinedione therapy in the management of type 2 diabetes mellitus.
- Pancreatic steatosis and its relationship to β-cell dysfunction in humans: racial and ethnic variations
- Restricted adipogenesis in hypertrophic obesity: the role of WISP2, WNT, and BMP4
- Perilipin 5 improves hepatic lipotoxicity by inhibiting lipolysis.
- Lipid droplet autophagy in the yeast Saccharomyces cerevisiae
|
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)